Public Citizen has great information about roof crush and rollover incidents on its website. The site informs about the dangers of rollovers and the automobile industry’s knowledge of those dangers. The site has a study of 54 rollovers and concludes that “the majority of roof damage occurs on the side…
Guidant Corporation, a medical device manufacturer, did not tell doctors or patients for three years that a unit implanted in an estimated 24,000 people that is designed to shock a faltering heart contains a flaw that has caused a small number of those units to short-circuit and malfunction. Defibrillators are…
A jury verdict for several plaintiffs who alleged that they were injured by the weight-loss supplement Metabolife 356 was recently reversed by the 11th Cir. Court of Appeals. The Court ruled that the expert testimony offered by the Plaintiff on the causation issue should not have survived at Daubert challenge.…
Read this release hot of the press from the New York Times: May 5, 2005 Merck Announces Resignation of Chief and Names Replacement By THE ASSOCIATED PRESS NEW YORK – Merck & Co. said Thursday that Raymond V. Gilmartin is stepping down effective immediately from the top leadership spots at…
A new article from Bloomberg reports that changes may have to be made to an Annals of Internal Medicine article linking Vioxx to heart problems. Here is the complete article. Tuesday, May 3, 2005 By JULIANN WALSH BLOOMBERG NEWS The Annals of Internal Medicine may publish a correction to a…
The Bush Administration’s solution to most problems is to cut taxes for people who make more than $100,000 per year. The Department of Homeland Security has figured out a different way to make our society safer from the threat of terrorists – extend immunity from suit to companies who make…
According to a press report, both sides to the nation’s first Vioxx trial have asked the judge to continue the trial date. The trial is set for May 23, 2005. Both sides asked for a continuance because federal judge Eldon E. Fallon, the judge presiding over the Vioxx MDL, asked…
For an unflattering look at the current state of the fen phen litigation look at this article from The American Lawyer.
The Food and Drug Administration has asked Pfizer to withdraw Bextra from the market “because the overall risk versus benefit profile for the drug is unfavorable.” Pfizer has agreed to do so pending further discussions with the agency. Here is a the FDA press release. The press release goes on…
Our firm is handling Vioxx cases. The MDL Panel has just sent all of the cases to the ED of Louisana for pretrial proceedings. Judge Fallon will be handling the case. The judge has set up a website for pretrial orders and proceedings. Here it is.